HZNP - Horizon Therapeutics Public Limited Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 55.07B
Enterprise Value 35.61B
Trailing P/E 77.46
Forward P/E 113.46
PEG Ratio (5 yr expected) 10.92
Price/Sales (ttm)3.95
Price/Book (mrq)3.33
Enterprise Value/Revenue 34.38
Enterprise Value/EBITDA 646.64

Trading Information

Stock Price History

Beta (3Y Monthly) 0.97
52-Week Change 338.05%
S&P500 52-Week Change 30.90%
52 Week High 329.44
52 Week Low 316.56
50-Day Moving Average 325.16
200-Day Moving Average 325.24

Share Statistics

Avg Vol (3 month) 32.02M
Avg Vol (10 day) 31.12M
Shares Outstanding 5164.98M
Float 183.93M
% Held by Insiders 11.20%
% Held by Institutions 182.74%
Shares Short (Jul 31, 2019) 46.28M
Short Ratio (Jul 31, 2019) 43.55
Short % of Float (Jul 31, 2019) 43.44%
Short % of Shares Outstanding (Jul 31, 2019) 43.37%
Shares Short (prior month Jun 28, 2019) 48.87M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 4.78%
Operating Margin (ttm)8.85%

Management Effectiveness

Return on Assets (ttm)1.84%
Return on Equity (ttm)5.14%

Income Statement

Revenue (ttm)1.28B
Revenue Per Share (ttm)7.40
Quarterly Revenue Growth (yoy)5.90%
Gross Profit (ttm)802.57M
EBITDA 120.24M
Net Income Avi to Common (ttm)61.24M
Diluted EPS (ttm)0.35
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)866M
Total Cash Per Share (mrq)4.64
Total Debt (mrq)1.4B
Total Debt/Equity (mrq)92.34
Current Ratio (mrq)2.20
Book Value Per Share (mrq)8.17

Cash Flow Statement

Operating Cash Flow (ttm)341M
Levered Free Cash Flow (ttm)289.24M